Lucira Health Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Lucira Health.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth16.1%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Lucira Health reports early data for point of care chlamydia and gonorrhea assays

Sep 29

Lucira COVID & Flu test gets emergency use authorization from Health Canada

Aug 11

Lucira Health Sees Strong Revenue Growth But Needs More Cash

Mar 10

Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher

Nov 25
Analysts' Revenue Estimates For Lucira Health, Inc. (NASDAQ:LHDX) Are Surging Higher

Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?

Jun 29
Is Lucira Health (NASDAQ:LHDX) In A Good Position To Invest In Growth?

Lucira Health appoints medtech veteran Kevin Collins as CRO

May 28

Health Canada issues 'authorization with conditions' for Lucira's COVID-19 test kit

Apr 26

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Lucira Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:LHDX.Q - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2022212-143-108-82N/A
6/30/2022193-44-118-97N/A
3/31/2022179-38-101-83N/A
12/31/202193-65-116-101N/A
9/30/202132-74-132-108N/A
6/30/202117-59-100-75N/A
3/31/20215-49-78-54N/A
12/31/20200-37-51-33N/A
9/30/2020N/A-22-24-18N/A
12/31/2019N/A-8-7-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LHDX.Q's forecast earnings growth is above the savings rate (2.2%).

Earnings vs Market: Insufficient data to determine if LHDX.Q's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if LHDX.Q's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if LHDX.Q's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if LHDX.Q's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if LHDX.Q's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.